Net effect of wealth on health for COVID-19 – worldwide state comparison

Author:

Żółtaszek AgataORCID,Olejnik AlicjaORCID

Abstract

The wealth-health relationship is not unambiguous and constant. Indeed, a higher level of wealth affects individual and population health in two opposite ways. Increased risk factors raise the probability of some diseases. Conversely, better healthcare and awareness reduce the chances of developing these diseases or raise the likelihood of treatment and cure. Therefore, the overall impact on health or the “net effect” of wealth (positive or negative) may be challenging to determine. Moreover, this effect may not be fixed for different income groups. Thus, it states to reason that there may exist an “affluence point” changing the predominant impact of wealth (positive/negative), which we will refer to as the “health economic threshold”. This paper aims to assess and quantify the hard-to-grasp overall impact of prosperity on the prevalence and mortality of COVID-19. In particular, we attempt to estimate both the net effect of affluence and the health economic threshold by applying a dedicated analytical tool and problem-specific forecasting methods. Namely, we employ the existing idea of joinpoint regression to produce a specification that models the relationship between GDP and prevalence or mortality which is allowed to exhibit non-constant monotonicity. Finally, we calculate the numerical value of the net effect of affluence through extrapolation. Our results show that for COVID-19 morbidity and mortality, up to a certain level of GDP, the richer the country, the higher the prevalence. After exceeding this threshold, the number of cases stabilises at a very high level, while mortality decreases along with the prosperity of countries. It turned out that the countries of Western and Northern Europe used their wealth effectively, significantly reducing mortality. Unfortunately, in CEE the net effect of wealth was insignificant. Therefore, even with relatively high levels of prosperity compared to the rest of the world, governments and health systems have not risen to the challenge.

Publisher

Adam Mickiewicz University Poznan

Reference31 articles.

1. Bilal M., Khan M.I., Nazir M.S., Ahmed I., Iqbal H.M.N. 2020. Coronaviruses and ­COVID-19 – Complications and Lessons Learned for the Future. Journal of Pure and Applied Microbiology,14 (suppl 1): 725-731.

2. Danaei G., Singh G.M., Paciorek K.J., Lin J.K., Cowan M.J., Finucane M.M., Farzadfa F., Stevens G.A., Riley L.M., Lu, Y., Rao M., Ezzati M. 2013. The Global Cardiovascular Risk Transition: Associations of Four Metabolic Risk Factors with Macroeconomic Variables in 1980 and 2008. Circulation, 127: 1493-1502.

3. Dyvesether S., Nordentoft M., Forman J., Erlangsen A. 2018. Joinpoint regression analysis of suicides in Denmark during 1980-2015. Danish Medical Journal, 65(4): 1-5.

4. Eurostat Database (https://ec.europa.eu/eurostat/data/database; accessed: 15.02.2021).

5. Farrell C. 2010. Mental Disorders. ABDO Publishing Company, North Mankato, Minnesota.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3